Clinical Study

4-Year Outcome Analysis of Endoscopic Vein Harvesting for Coronary Artery Bypass Grafting

Table 6

Logistic regression model to generate propensity scores for EVH group ( ) versus control group ( = 1,219).

EffectPoint estimate 95% Wald confidence limitsP value
LowerUpper

Age0.7810.5911.1170.21
Gender0.7430.5981.0510.20
Diabetes0.7860.6111.0870.17
Hypertension1.1120.9761.6370.41
Hypercholesterolemia1.5961.2312.1010.54
PVD0.8960.6591.1140.27
Previous stroke/TIA1.1130.8321.9870.63
COPD0.9860.7321.3470.47
Creatinine ≥ 200 µmol·L−10.9430.7551.1210.24
Prior PCI1.7511.4312.3210.59
Recent MI0.8490.6231.2970.22
LVEF > 50%0.9770.7221.1430.27
LVEF < 50%1.4461.3311.9210.43
Elective0.7240.6651.0330.21
Urgent0.6740.4751.0110.22
Single vessel1.1280.8221.9840.61
Two vessels1.0120.7761.3560.47
Three vessels0.9970.7821.1340.24
Logistic EuroSCORE0.9210.7471.151 0.27

COPD: chronic obstructive pulmonary disease; EVH: endoscopic vein harvest; LVEF: left ventricle ejection fraction; OVH: open vein harvest; PVD: peripheral vascular disease; and TIA: transient ischemic attack.